0:00

My name is a, I am a cardiothoracic radiologist at the

0:04

University of Michigan, and I'd like to welcome you

0:06

to the Lung Cancer Screening Mastery Course.

0:10

I've been practicing at the University of Michigan

0:12

for over 30 years, where I was an undergraduate

0:14

and went to medical school

0:15

and an integrated six year program.

0:17

I was fortunate to do my fellowship at Massachusetts General

0:21

in Boston, and I've been a professor now

0:23

at the University of Michigan.

0:24

Since then, I truly embrace the tripartite mission

0:28

of clinical care, education, and research

0:30

and how they intersect with each other to advance the care

0:34

that we deliver to our patients.

0:35

I'm passionate about the integral role of radiology

0:38

and the diagnostic process

0:40

and improving patient care through research,

0:43

and then implementing those new techniques

0:45

into clinical practice.

0:47

Lastly, I'm a big believer in chest CT

0:49

as a population health tool.

0:51

Lung cancer screening is population health at its finest in

0:55

radiologist hands.

0:56

And there are other components of lung cancer screening such

0:59

as detecting bone mineral demineralization with osteoporosis

1:03

or coronary calcium.

1:04

That can also add to the population health.

1:08

The diagnostic process was well articulated in this book

1:11

from the Institute of Medicine on improving the diagnostic

1:14

process, and radiologists are part

1:17

of this diagnostic process from when a patient experiences a

1:20

health problem at the beginning

1:22

to when there are treatment and outcomes.

1:25

The radiologist component

1:26

of the diagnostic pathway is essential in diagnostic

1:30

testing, and in our case,

1:31

we're gonna talk about lung cancer screening

1:33

to identify things to improve patient health.

1:37

So the goals of this course are to understand who's eligible

1:41

for lung cancer screening

1:42

and why to develop a systematic approach to interpreting

1:45

and reporting lung cancer screening cts,

1:47

including the tools we use at the workstation when

1:50

interpreting exams on the pax,

1:53

to develop a deeper understanding of how to use long rans

1:56

to distinguish between low risk lesions versus high risk

1:59

findings that may be cancer,

2:01

and how to appropriately manage them

2:04

and to learn the importance

2:05

of identifying common incidental findings

2:07

and recommending appropriate management as people

2:10

who have had

2:11

or currently do smoke, have increased risks

2:14

of cardiovascular disease, abnormal bone mineral density,

2:18

COPD and other malignancies.

2:21

The foundations of this course are screening guidelines

2:25

and eligibility criteria.

2:26

We need to understand who we're screening

2:29

and why we're screening them based on the evidence.

2:32

The role of the radiologist

2:34

and the radiology practice in lung cancer screening is

2:36

imperative to understand

2:38

and where do we fit In the lung Rat Structured reporting

2:41

and management tool is the fundamental tool

2:43

for interpretation and then reporting considerations,

2:46

including the use of structured reports

2:49

and patient letters to better communicate

2:51

with the patients who are being screened.

2:53

And with our referring physicians.

2:56

We're going to use a systematic approach to interpreting

2:59

Lung cancer screening cts.

3:00

We'll look at the different tools that are available

3:02

to you at a PAX workstation to look at these examinations,

3:07

MULTIPLANAR meps, and tools that can help you find

3:10

and characterize nodules.

3:12

We'll do this deep dive into understanding how

3:14

to use lung rads and why we make determinations

3:17

of what's a low risk nodule and a high risk nodule.

3:20

So you know why we make decisions about following some

3:23

nodule sooner and letting other nodules sit

3:26

until the next annual screen.

3:29

The approach to common incidental findings is very important

3:32

to understand what we need to do,

3:33

not only in identifying them,

3:35

but in what management recommendations we're going to give

3:39

so that patients receive the appropriate next steps in care.

3:43

So let's dig in together.

3:44

I'm excited to be on this journey with you

3:46

to learn more about lung cancer screening.